Delek US Holdings, Inc. DK ← Back to all reports

Delek US Holdings, Inc.

DK · Energy
B ★★★ Hold
Aug 20, 2026 · Score 84 · Type A — Value-style analysis Used for established, cash-generative companies — weighs earnings power, valuation against the company's own history and peers, and margin of safety. Full methodology →
Current PriceThe market price around the time this report was written — not a live quote. The market has moved since; check a current price before acting.Methodology → $66.33
Buy ZoneThe large figure is the midpoint of the suggested buy range shown in parentheses. $60.00 ($55.00–$65.00)
Price TargetOur estimated fair value. For richly valued stocks it can sit below the current price — see Methodology.Methodology → $74.02
Expected Return
  • Target relative to the Current Price ((Target − Current) ÷ Current). Since that price is from the report date, your actual return will differ.
  • A negative figure isn't an error. For richly valued stocks, the fair-value target can sit below the current price, so the return reads negative. The grade reflects company quality; this figure reflects today's entry valuation.
Methodology →
+11.6%

Type A - Delek US Holdings, Inc. (DK) 20260820 Stock Analysis

📅 Delek US Key Upcoming Events

🏢 Step 1: Delek US Company Overview & Business Model

Q1-A1. What is Delek US?

Q1-A2. How Does Delek US Make Money?

Q1-A3. Delek US’s Revenue Segments & Core Income Sources

Q1-A4. Who Are Delek US’s Competitors?

Q1-A5. Delek US Key Events: Past 12 Months

Q1-A6. Step 1 Key Takeaways

🏰 Step 2: Delek US’s Economic Moat, Growth & Capital Allocation

Q2-A1. Does Delek US Have a Durable Economic Moat?

Q2-A2. Is Delek US’s Growth Sustainable?

Q2-A3. How Does Delek US Allocate Capital & Return Cash?

Q2-A4. Step 2 Key Takeaways

💰 Step 3: Is Delek US Profitable? Financial Health Analysis

Q3-A2. How Profitable Is Delek US? (Margins & ROIC)

Q3-A3. What Drives Delek US’s Returns? (ROIC Breakdown)

Q3-A4. Are Delek US’s Earnings High Quality?

Q3-A5. Is Delek US’s Balance Sheet Healthy? (Debt & Leverage)

Q3-A6. Step 3 Key Takeaways

🔎 Step 4: Delek US Forensic Accounting & Dilution Review

Q4-A1. Does Delek US Have Accounting Red Flags?

Q4-A2. Is Delek US Overspending? (Capex & Capital Cycle)

Q4-A3. How Sound Is Delek US’s Cash Flow?

Q4-A4. Is Delek US Diluting Shareholders?

Q4-A5. Data Integrity Check

Q4-A6. Step 4 Key Takeaways

👔 Step 5: Delek US Management & Shareholder Alignment

Q5-A1. Can You Trust Delek US’s Management? (Guidance Track Record)

Q5-A2. What Are Delek US Insiders Doing?

Q5-A3. Is Delek US’s Management Aligned With Shareholders?

Q5-A4. Step 5 Key Takeaways

⛵ Step 6: Delek US Market Flow & Sentiment

Q6-A1. Analyst Consensus vs Delek US Guidance

Q6-A2. What Is Delek US’s Short Interest?

Q6-A3. Step 6 Key Takeaways

🚀 Step 7: Delek US Catalysts & Price Triggers

Q7-A1. What Could Move Delek US Stock? (Top 3 Catalysts)

Q7-A2. Delek US’s Earnings Revision Trend

Q7-A3. Step 7 Key Takeaways

⚖️ Step 8: Is Delek US Fairly Valued? Valuation Analysis

Q8-A1. Delek US’s Key Valuation Multiples (P/E, EV/EBITDA)

Q8-A2. Delek US vs Peers: Valuation Comparison

Q8-A3. Is Delek US Cheap or Expensive vs Its History?

Q8-A4. What Growth Is Priced Into Delek US? (Reverse DCF)

Q8-A4-1. What Growth Hurdle Does the Market Demand From Delek US? (Reverse DCF Alternative)

Q8-A5. Valuation Cross-Check

Q8-A6. Delek US’s Hidden Asset & Stake Valuation

Q8-A7. Final Valuation Adjustment

Q8-A8. Valuation Adjustment Score Calculation

💀 Step 9: What Are the Risks of Delek US? Fatal Risks & Pre-Mortem

Q9-A1. What Are the Biggest Risks to Delek US?

Q9-A2. How Sensitive Is Delek US to the Economy?

Q9-A3. Delek US Pre-Mortem: What Could Go Wrong?

Q9-A4. Risk Adjustment Score

🎯 Step 10: Delek US Final Verdict: Score & Rating

Q10-A1. Investment Score & Rating

Q10-A2. Should You Buy Delek US? (Recommendation)

Q10-A3. Investment Thesis in One Line

Q10-A4. Delek US’s Price Trend & Key Drivers

Q10-A5. Action Plan

🕵️‍♂️ Deep Dive Analysis

Q1: Is Delek US’s Reliance on EPA Small Refinery Exemptions Its Biggest Weakness?

Q2: Can Delek US’s 5.39x Forward P/E Be Justified by the Current Crack Spread Cycle?

Q3: Will the Deconsolidation of Delek Logistics Partners Unchain Delek US’s Valuation?

Q4: How Does the Enterprise Optimization Plan Structurally Alter Delek US’s Margin Profile?

Q5: Are Elevated Permian Crude Access Advantages Sustainable for Delek US?

Q6: Can Amber Russell’s Leadership Catalyze a Meaningful Turnaround in Delek US’s Refining Yields?

Q7: Does Delek US’s High Leverage Profile Pose an Existential Threat in a Margin Downcycle?

Q8: Is Delek US’s Robust Dividend Yield Truly Secure Amid Volatile Cash Flows?

Q9: How Vulnerable Is Delek US’s Midstream Segment to a Permian Basin Production Slowdown?

Q10: Could Delek US Emerge as a Prime Acquisition Target in the Consolidating Energy Sector?